Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Inventory (2019 - 2025)

Legend Biotech filings provide 7 years of Inventory readings, the most recent being $32.0 million for Q4 2025.

  • On a quarterly basis, Inventory rose 33.89% to $32.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.0 million, a 33.89% increase, with the full-year FY2025 number at $32.0 million, up 33.89% from a year prior.
  • Inventory hit $32.0 million in Q4 2025 for Legend Biotech, up from $29.2 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $35.6 million in Q2 2025 to a low of $1700.0 in Q2 2021.
  • Median Inventory over the past 5 years was $18.4 million (2023), compared with a mean of $16.5 million.
  • Biggest five-year swings in Inventory: fell 2.83% in 2021 and later soared 137954.36% in 2022.
  • Legend Biotech's Inventory stood at $1.7 million in 2021, then skyrocketed by 492.0% to $10.4 million in 2022, then soared by 87.69% to $19.4 million in 2023, then grew by 22.99% to $23.9 million in 2024, then soared by 33.89% to $32.0 million in 2025.
  • The last three reported values for Inventory were $32.0 million (Q4 2025), $29.2 million (Q3 2025), and $35.6 million (Q2 2025) per Business Quant data.